KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Common Equity: 2009-2025

Historic Common Equity for Idexx Laboratories (IDXX) over the last 16 years, with Sep 2025 value amounting to $1.6 billion.

  • Idexx Laboratories' Common Equity fell 3.51% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year decrease of 3.51%. This contributed to the annual value of $1.6 billion for FY2024, which is 7.46% up from last year.
  • Per Idexx Laboratories' latest filing, its Common Equity stood at $1.6 billion for Q3 2025, which was up 7.02% from $1.5 billion recorded in Q2 2025.
  • Idexx Laboratories' Common Equity's 5-year high stood at $1.6 billion during Q3 2024, with a 5-year trough of $457.0 million in Q2 2022.
  • Moreover, its 3-year median value for Common Equity was $1.5 billion (2023), whereas its average is $1.4 billion.
  • As far as peak fluctuations go, Idexx Laboratories' Common Equity surged by 551.00% in 2021, and later crashed by 38.92% in 2022.
  • Over the past 5 years, Idexx Laboratories' Common Equity (Quarterly) stood at $690.0 million in 2021, then declined by 11.78% to $608.7 million in 2022, then spiked by 143.87% to $1.5 billion in 2023, then rose by 7.46% to $1.6 billion in 2024, then decreased by 3.51% to $1.6 billion in 2025.
  • Its Common Equity was $1.6 billion in Q3 2025, compared to $1.5 billion in Q2 2025 and $1.4 billion in Q1 2025.